Y Combinator Startup Podcast
#64 - Researching Psilocybin's Effects on Depression - Dr. Rosalind Watts
Mar 15, 2018
Dr. Rosalind Watts, clinical psychologist at the Psychedelic Research Group at Imperial College London, discusses the history and resurgence of psilocybin research, embracing difficult emotions and surrendering in psychedelic experiences, the effects of psilocybin on depression, the role of psilocybin in therapy, accessing altered states beyond psychedelics, and maintaining change and connecting to self and others.
53:45
Episode guests
AI Summary
AI Chapters
Episode notes
Podcast summary created with Snipd AI
Quick takeaways
- Psilocybin deactivates the part of the brain responsible for rumination and negative thinking, showing potential for treating individuals with treatment-resistant depression.
- Psychedelic research faced a decline in the past but has resurged in the early 2000s, leading to studies on the effects of psilocybin.
Deep dives
The Focus of the Psychedelic Research Group
The podcast episode features Dr. Rosalind Watts, a clinical psychologist at the psychedelic research group at Imperial College of London. The group focuses on studying the action of psychedelic drugs in the brain and their clinical utility.
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
